Vaccine Development Challenges: Viral Mutation, Antigenic Drift & Shift

Viral genetic variation challenges vaccine development:

  • Antigenic drift – Accumulated mutations (e.g., influenza) alter surface proteins, reducing antibody effectiveness.
  • Antigenic shift – Major genetic reassortment (e.g., influenza A) creates novel subtypes unrecognized by immunity.
  • Immune escape – Viruses like HIV rapidly mutate surface proteins to evade antibodies.
  • Drug-resistant variants – Antiviral pressure selects resistant mutants, complicating vaccines.

Strategies include broad-spectrum vaccines targeting conserved regions, genomic surveillance, and mRNA platforms for rapid adaptation.

Viral Infections - Related Articles